摘要近年来,人工智能(AI)技术发展迅速,已经成为医学领域的研究前沿热点之一.基于人工神经网络的深度学习算法是其中最具代表性的工具.眼科学的进步有赖于多种影像手段的进步,而AI技术的便捷性和高效性使其在眼科疾病筛查、诊疗以及随访中表现出巨大的应用前景.当前,眼科AI技术的相关研究围绕多病种和多模态两个方面展开,在眼科常见疾病方面已经有许多有价值的成果相继报道.需要强调的是,眼科AI产品在实际应用方面仍然面临一些问题,监管机制和评价标准尚未形成一个完整和统一的体系,在大范围投入临床使用前还有诸多方面亟待优化.眼科AI技术的创新是多学科融合的产物,对我国公共卫生事业具有相当重要的意义,也必将在临床实践中使广大患者获益.

abstractsFor the past few years,artificial intelligence (AI) technology has developed rapidly and has become frontier and hot topics in medical research.While the deep learning algorithm based on artificial neural networks is one of the most representative tool in this field.The advancement of ophthalmology is inseparable from a variety of imaging methods,and the pronounced convenience and high efficiency endow AI technology with promising applications in screening,diagnosis and follow-up of ophthalmic diseases.At present,related research on ophthalmologic AI technology has been carried out in terms of multiple diseases and multimodality.Many valuable results have been reported aiming at several common diseases of ophthalmology.It should be emphasized that ophthalmic AI products are still faced with some problems towards practical application.The regulatory mechanism and evaluation criteria have not yet integrated as a standardized system.There are still a number of aspects to be optimized before large-scale distribution in clinical utility.Briefly,the innovation of ophthalmologic AI technology is attributed to multidisciplinary cooperation,which is of great significance to China's public health undertakings,and will be bound to benefit patients in future clinical practice.